Patricia J. Zettler

Patricia J. Zettler's work examines how the U.S. Food and Drug Administration (FDA) regulates drugs, vaccines, medical devices, cell and gene therapies, and tobacco/nicotine products, including legal disputes and policy debates around these regulations. Her writing often addresses timely controversies such as FDA responses to court rulings, drug approval standards, nicotine and vaping products, and access to unproven cell and gene therapies. This research is aimed at informing both legal and medical audiences about the practical and legal consequences of FDA policy decisions.

Publication output has fluctuated over the last decade without a clear upward or downward trend, generally ranging between about 4 and 12 papers per year, with a recent average of about 6 per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026